Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $369.9500 (-2.06%) ($365.9300 - $377.4300) on Fri. May. 6, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.96% (three month average) | RSI | 30 | Latest Price | $369.9500(-2.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.4% a day on average for past five trading days. | Weekly Trend | REGN declines -4.7% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(63%) XLV(51%) XBI(47%) IVW(41%) QQQ(41%) | Factors Impacting REGN price | REGN will decline at least -1.48% in a week (0% probabilities). VIXM(-11%) UUP(-8%) TLT(-8%) IPO(-5%) SHY(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.48% (StdDev 2.96%) | Hourly BBV | 0 () | Intraday Trend | -1.7% | | | |
|
Resistance Level | $394.86 | 5 Day Moving Average | $372.83(-0.77%) | 10 Day Moving Average | $382.79(-3.35%) | 20 Day Moving Average | $394.86(-6.31%) | To recent high | -13.4% | To recent low | 2.9% | Market Cap | $39.225b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |